These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2634330)

  • 1. [Problems of diagnosis and classification related to the improper use of substances in the DSM-III and DSM-III-R].
    Mata EA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):31-8. PubMed ID: 2634330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Substance-induced disorders: moving towards DSM-V and ICD-11].
    Schmidt LG
    Fortschr Neurol Psychiatr; 2006 Nov; 74(11):634-42. PubMed ID: 16586255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of nosologically informative data sets that address key diagnostic issues facing the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) and International Classification of Diseases, eleventh edition (ICD-11) substance use disorders workgroups.
    Cottler LB; Grant BF
    Addiction; 2006 Sep; 101 Suppl 1():161-9. PubMed ID: 16930173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Addictive behaviours from DSM-IV to DSM-5].
    van den Brink W
    Tijdschr Psychiatr; 2014; 56(3):206-10. PubMed ID: 24643833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed changes in DSM-III substance use disorders: description and rationale.
    Rounsaville BJ; Spitzer RL; Williams JB
    Am J Psychiatry; 1986 Apr; 143(4):463-8. PubMed ID: 3953889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical diagnosis in sleep laboratory patients based on ICD-10, DSM-III-R and ICSD classification criteria].
    Saletu B; Gruber G; Mandl M; Becker B; Ben-Chur R; Damianisch K; Parapatics S; Stanger E; Tschida U; Winkler A
    Wien Med Wochenschr; 1995; 145(24):656-62. PubMed ID: 8585219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance dependence and non-dependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD): can an identical conceptualization be achieved?
    Saunders JB
    Addiction; 2006 Sep; 101 Suppl 1():48-58. PubMed ID: 16930161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild disorders should not be eliminated from the DSM-V.
    Kessler RC; Merikangas KR; Berglund P; Eaton WW; Koretz DS; Walters EE
    Arch Gen Psychiatry; 2003 Nov; 60(11):1117-22. PubMed ID: 14609887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and remaining problems with DSM-V.
    Uchtenhagen A
    Addiction; 2011 May; 106(5):888-9; discussion 895-7. PubMed ID: 21477240
    [No Abstract]   [Full Text] [Related]  

  • 11. Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V.
    Nunes EV; Rounsaville BJ
    Addiction; 2006 Sep; 101 Suppl 1():89-96. PubMed ID: 16930164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body dysmorphic disorder: does it have a psychotic subtype?
    McElroy SL; Phillips KA; Keck PE; Hudson JI; Pope HG
    J Clin Psychiatry; 1993 Oct; 54(10):389-95. PubMed ID: 8262881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DSM-III: the 3d edition of the Diagnostic and Statistical Manual of Mental Disorders from the American Psychiatric Association].
    Pichot P
    Rev Neurol (Paris); 1986; 142(5):489-99. PubMed ID: 3787052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multinational validation of the Composite International Diagnostic Interview (CIDI)].
    Tacchini G; Coppola MT; Musazzi A; Altamura AC; Invernizzi G
    Minerva Psichiatr; 1994 Jun; 35(2):63-80. PubMed ID: 7934738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep disorders related to another mental disorder (nonsubstance/primary): a DSM-IV literature review.
    Nofzinger EA; Buysse DJ; Reynolds CF; Kupfer DJ
    J Clin Psychiatry; 1993 Jul; 54(7):244-55; discussion 256-9. PubMed ID: 8335651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V?
    Helzer JE; van den Brink W; Guth SE
    Addiction; 2006 Sep; 101 Suppl 1():17-22. PubMed ID: 16930157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Child and adolescent psychiatric classification in an unselected sample--a comparison of MAS and DSM-III].
    Blanz B; Schmidt MH
    Z Kinder Jugendpsychiatr; 1986; 14(4):296-307. PubMed ID: 3825307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSM-III-R: too much too soon?
    Rey JM
    Aust N Z J Psychiatry; 1988 Jun; 22(2):173-82. PubMed ID: 3041959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.
    Radat F; Creac'h C; Guegan-Massardier E; Mick G; Guy N; Fabre N; Giraud P; Nachit-Ouinekh F; Lantéri-Minet M
    Headache; 2008 Jul; 48(7):1026-36. PubMed ID: 18081820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.